In recent years both weight loss injections and “microdosing” have become increasingly popular — and now, so is combining the two. Injections originally intended to treat Type 2 diabetes, like Ozempic and Mounjaro, are proven to help people lose weight, but are often associated with side effects like gastrointestinal issues, which is why people have started microdosing these drugs. Microdosing is when people take less than the prescribed or reco…

Straight Arrow News

'Microdosing' is the new trend in weight loss, but is it safe?

The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs. Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital in Boston, joins CBS News to assess the safety and risks of the practice.

Ad Fontes Media

All Sides

Media Bias/Fact Check

CBS News

National Amusements

Michael Redstone

Some health experts warn against microdosing weight loss drugs

It is approved by ANMAT against type 2 diabetes, but it is not the first time that a drug is used for another purpose.To the highly demanded presentation of injection was added another one in tablets, whose sales were also shot.

Está aprobado por la ANMAT contra la diabetes tipo 2, pero no es la primera vez que un medicamento se usa para otro fin.A la muy demandada presentación inyectable se le sumó otra en comprimidos, cuyas ventas también se dispararon.

Polémica por el uso del Ozempic para adelgazar: quiénes están a favor, quiénes en contra y por qué

Clarin

Clar%C3%ADn Group

Buenos Aires

Argentina

Polemic for the use of Ozempic to lose weight: who is in favor, who is against and why

The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs. Dr. Jeremy Faust, emergency physician at Brigham and Women’s Hospital in Boston, joins CBS News to assess the safety and risks of the practice. Source …

News Talk 94.1/AM 1600

World, Dec 10, 2024 (ATB Digital).- Some people take tiny amounts of weight loss drugs with the hope of losing weight without suffering the side effects. This is what the experts say. Erica Liebman wanted to lose weight, but it made her nervous to try a medication like the Ozempic. Liebman, a psychologist from Philadelphia, had heard horror stories about side effects: nausea, vomiting, intense constipation. So Liebman resorted to a solution that…

Mundo, 10 de dic 2024 (ATB Digital).- Algunas personas toman cantidades minúsculas de fármacos para adelgazar con la esperanza de perder peso sin sufrir los efectos secundarios. Esto dicen los expertos. Erica Liebman quería perder peso, pero la ponía nerviosa probar un medicamento como el Ozempic. Liebman, psicóloga de Filadelfia, había oído historias de terror sobre efectos secundarios: náuseas, vómitos, estreñimiento intenso. Así que Liebman r…

Nuevos medicamentos para adelgazar: ¿funcionan las microdosis?

ATB Digital

New slimming drugs: do microdoses work?

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating alcoholism and other addictions, or are they too good to be true?

Men's Health

Weight-Loss Drugs Saved Me From Alcoholism

beckershospitalreview.com

Experts torn on Ozempic microdosing

The use of anti-obesity drugs, GLP-1 agonists, could be effective for patients suffering from alcoholism. A study published in November has found that people who receive treatment with incretinic drugs, such as in cases of the aforementioned obesity -Mounjaro or Wegovy- or for type 2 diabetes - such as Ozempic-"show an improvement in the control of alcohol addiction", according to Irene Bretón, coordinator of the Obesity Area of the Spanish Soci…

El uso de fármacos contra la obesidad, agonistas del GLP-1, podrían ser eficaces para los pacientes que padecen alcoholismo. Un estudio publicado en noviembre ha observado que las personas que reciben tratamiento con fármacos incretínicos, como en los casos de la ya citada obesidad -Mounjaro o Wegovy- o para la diabetes tipo 2 - como Ozempic-"presentan una mejoría en el control de la adicción al alcohol", según Irene Bretón, coordinadora del Áre…

Fármacos para la obesidad: la nueva "promesa" contra el alcoholismo

redaccionmedica.com

Obesity drugs: the new "promise" against alcoholism

(New York Times) – Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it work? At this point, doctors aren’t sure. Theoretically, these medications are so potent that perhaps even tiny doses could curb hunger somewhat, said Dr. Daniel Drucker, a researcher at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto and one of the first scientists to study med…

'Microdosing' is the new trend in weight loss, but is it safe?

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics